- videocam Live Webinar with Live Q&A
- calendar_month April 30, 2026 @ 1:00 p.m. ET./10:00 a.m. PT
- signal_cellular_alt Intermediate
- card_travel Health
- schedule 90 minutes
ACOs, Clinically Integrated Networks, and Super CINs: Must Know Emerging Legal and Regulatory Developments for Nonprofit, For Profit, and Private Equity Backed Participants
Welcome to BARBRI, the trusted global leader in legal education. Continue to access the same expert-led Strafford CLE and CPE webinars you know and value. Plus, explore professional skills courses and more.
About the Course
Introduction
This CLE course will provide an overview of "must know" legal, regulatory, and case law developments that are important to the future formation and operation of hospital and physician clinically integrated networks (CINs) and Accountable Care Organizations (ACOs). The topics will include recent regulatory activity, court actions and emerging issues of federal and state antitrust law, healthcare fraud, waste and abuse laws, information privacy and data sharing regulations, corporate practice of medicine and fee splitting restrictions, and state and federal tax law. Understanding these emerging issues can help providers ensure that their participation in value-based care is a sound and productive venture that advances the work of providers to meet community and stakeholder needs. The course will provide an opportunity for Q&A to allow listeners to focus the discussion on what is most relevant to them.
Description
Recent market shifts and a variety of federal and state incentives make participation in ACOs and CINS a potential option for hospital and physician providers to collaborate, manage costs, and improve quality and efficiency in healthcare delivery.
Against this backdrop, several recent large CIN and ACO transactions (including creation of "Super-CINs"), litigation matters, and regulatory and statutory changes provide an important roadmap for providers participating in or considering such collaborations to optimize benefit.
Listen as our authoritative panel of experts provides an in-depth discussion of new and emerging legal and regulatory considerations that may impact the landscape for hospitals, physicians, and payors as they consider or advance their participation in or oversight of a CIN or ACO.
Presented By
Mr. Daniel practices exclusively in the healthcare transactional and regulatory areas. He devotes his efforts to physician transactions, joint ventures, mergers and acquisitions, contracting and regulatory matters, and healthcare providers of all types. In connection with these matters, Mr. Daniel routinely provides advice on issues related to tax-exempt status, including private inurement, private benefit, and intermediate sanctions, tax-exempt financing, antitrust compliance and fraud and abuse. Since 2010, Mr. Daniel dedicates his time and efforts counseling clients in strategy development under evolving patient payment models, including the planning and development of medical homes, accountable care organizations, direct contracting entities, and clinically integrated networks. He is a frequent speaker and facilitator on healthcare strategy and physician alignment issues. Mr. Daniel advises long term care facilities, home health agencies, hospices, durable medical equipment companies and other providers on legal and regulatory matters.
Ms. Ferrari is a member of Hancock Daniel’s corporate healthcare group, where she focuses on issues related to transactional and enterprise compensation planning, governance and review, particularly issues related to fair market value and commercial reasonableness. Although her past experience encompasses a multitude of regulatory, transactional, governance and investigation matters, Ms. Ferrari is known especially for her work in recruitment and retention of highly compensated thought leader physicians and executives; and incentive payment distributions through ACOs and clinically integrated networks to advance value-based care initiatives. She has worked extensively with clients navigating the intersection of regulatory and financial considerations in clinical research, including agreements for funding and support services and the related issues of contracting and compliance; transactional due diligence for compensation compliance; and navigating the intersection of compensation and antitrust issues. Ms. Ferrari's expertise also includes recruitment, compensation and procurement governance for “essential” hospitals such as public, rural, academic and pediatric hospitals.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Thursday, April 30, 2026
- schedule
1:00 p.m. ET./10:00 a.m. PT
I. Overview of selected key recent and proposed changes and case law developments in federal and state antitrust law; healthcare fraud, waste and abuse laws; payor regulations; information privacy and data sharing; state licensing and fiduciary requirements; corporate practice of medicine restrictions; and state and federal nonprofit and for-profit tax law
II. Current and future organizational and governance issues in the evolving regulatory environment, including issues related to monitoring and maximizing participant financial incentives while ensuring compliant, fair market value, and commercially reasonable payments
III. What can be learned from recent case law and examples in the market
IV. Suggestions for best practices going forward, including for information tracking and sharing, management and governance, and payments of incentives and distributions
The panel will review these and other key issues:
- Regulatory compliance and due diligence questions CINs and ACOs face under the emerging federal and state legal and regulatory landscape, including fraud, waste and abuse laws; antitrust; corporate practice of medicine; fee splitting; tax exemption laws and regulations; and emerging issues for corporate fiduciaries.
- Factors healthcare providers, nonprofit and corporate sponsors, and their counsel should consider when selecting and managing value-based population health incentive programs in 2025/2026.
- When and why contributions to and payments from a CIN should be evaluated for fair market value and reasonableness.
- Special considerations when CIN participants enter or leave a network, are hospital-employed physicians, not-for-profit entities, and/or private equity investors.
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
OIG Modernized Medicare Advantage Compliance Guidance: Key Updates, Provider Risks, Evaluating Compliance Programs
Tuesday, May 5, 2026
1:00 PM ET/10:00 AM PT
ACOs, Clinically Integrated Networks, and Super CINs: Must Know Emerging Legal and Regulatory Developments for Nonprofit, For Profit, and Private Equity Backed Participants
Thursday, April 30, 2026
1:00 p.m. ET./10:00 a.m. PT
Private Equity Transactions in Healthcare: Stark, AKS, and Other Compliance Challenges
Wednesday, May 20, 2026
1:00 PM ET/10:00 AM PT
Employment Agreements for Non-Physician Health Professionals: Legislative Trends and Developments, Key Provisions
Wednesday, April 29, 2026
1:00 p.m. ET/10:00 a.m. PT
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement